Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse
- 11 September 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 371 (1) , 79-83
- https://doi.org/10.1016/j.neulet.2004.08.045
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2003
- Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic PatientsJournal of Psychopharmacology, 2003
- Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylationExperimental Neurology, 2003
- Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controlsNeuroscience Letters, 2003
- Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injuryIntensive Care Medicine, 2003
- Cannabis and the brainBrain, 2003
- Cell biology of the hippocampal formation in schizophreniaBiological Psychiatry, 1999
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult HippocampusScience, 1995
- CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish ConscriptsThe Lancet, 1987